1. CMS and Its Claims Processing Contractors Issued Conflicting Guidance on the Proper Use of the KX Modifier for Part B Immunosuppressive Drug Claims - “Medicare Part B paid for some immunosuppressive drugs billed with the KX modifier that were not eligible for Part B payment.
Compliance News Roundup: The Many Faces of False Claims Act Allegations
September 20, 2017 | Posted by :
Healthicity
Healthicity
